Alcohol-Associated Liver Disease of a Digital Clinic Implementation

Overview

About this study

The purpose of this study is to determine whether a multidisciplinary digital clinic will improve health outcomes, reduce costs, increase access, and improve patient and provider satisfaction.
 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects over the age of 18 years.
  • Alcohol-associated liver disease.
  • Active alcohol use disorder.
  • Alcohol use disorder within prior 6 months.

Exclusion Criteria:  

  • Lack of access to smart phone.
  • Hospice care or identified as end of life by provider.
  • Post liver transplant patients.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/18/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Douglas Simonetto, M.D.

Open for enrollment

Contact information:

Amy Olofson R.N.

(507) 538-6547

Olofson.Amy@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Blanca Lizaola-Mayo, M.D.

Open for enrollment

Contact information:

Blanca Lizaola-Mayo M.D.

(480) 574-2104

Lizaola-Mayo.Blanca@mayo.edu

More information

Publications

Publications are currently not available